Clinical Trial Update: First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer [Phase 1]

View source ↗

Summary

This first-in-human Phase 1 trial reports safety, tolerability, and preliminary antitumor activity of MTL-CEBPA in patients with advanced hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MTL-CEBPA

Snippet

Sponsor: Mina Alpha Limited | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 1 | Status: UNKNOWN